Jul 19, 2017 12:42 pm UTC| Business
HOUSTON, July 19, 2017 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that it is commencing concurrent offerings of $3.25 billion of shares of its common stock and $1.5 billion of shares...
Jul 19, 2017 12:31 pm UTC| Business
BOSTON, July 19, 2017 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced that it will host a conference...
Jul 19, 2017 12:30 pm UTC| Business
RA’ANANA, Israel, and NEW YORK, July 19, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...
Cyclacel Announces Pricing of $13.2 Million Underwritten Public Offering
Jul 19, 2017 12:30 pm UTC| Business
BERKELEY HEIGHTS, N.J., July 19, 2017 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage...
CymaBay Announces Pricing of Public Offering of Common Stock
Jul 19, 2017 12:30 pm UTC| Business
NEWARK, Calif., July 19, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
Jul 19, 2017 12:30 pm UTC| Business
VANCOUVER, British Columbia, July 19, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTC:MGXMF) is pleased to report a nine hole diamond drill program is underway at the Company’s Longworth...
Jul 19, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., July 19, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare...